top of page

Access China Biotech Forum 2023

We are pleased to inform you about the webinar "Access China Biotech Forum” which will be held online and onsite during the JP Morgan Week on January 2023.

As the largest China corporate access event during the JP Morgan Week in 2023, the forum expects to have over 1000 participants from China pharma and Biotech companies. Access China is the most effective deal-making platform for Western pharma and biotech leaders looking to enter or expand in the chinese market. Access ChinA creates invaluable business development opportunities by directly connecting and meeting with the right partners for development, licensing or commercial collaborations.

In 2021 there has been 29 China out-licensing and 93 in-licensing transactions successfully closed, representing a 20% year on year growth. It is a symbol of the rise of China biotech innovation as a result of China’s massive investment and favorable regulatory changes. As a facilitator between China biotech innovation and the rest of the world, our forum plans to present +50 China and +50 global biotech companies who are looking for partnering opportunities.

Lorenzo Riccardi, Managing Director of RsA Asia, will participate in the event as a speaker.


Recent articles
bottom of page